The numbers at a glance
Key figures
| Women accessing PBS-priced endometriosis treatment | More than 11,000 |
|---|---|
| Government-reported prescriptions | About 600,000 |
| Reported savings | About $11.7 million |
| Previous annual cost to some Ryeqo patients | Up to $2,700 |
| PBS co-payment 2026 | Up to $25 general, $7.70 concession |
PBS co-payments are per eligible prescription. The amount for an individual medicine can also depend on the PBS item, prescription conditions and any applicable premium.
Source: Australian Government announcement dated 7 September 2026. Its reported prescription and savings figures cover endometriosis treatments overall and are not specific to Ryeqo. PBS listings and pharmacy prices can change.
Endometriosis medicine costs: PBS and private examples
The PBS figures apply only when the specific medicine and prescription meet the listing conditions. Private prices are retailer examples reported in October 2026, not guaranteed quotes; confirm the current price and availability with a pharmacy.
| Medicine | Form | PBS general | PBS concession | Private example |
|---|---|---|---|---|
| Visanne (dienogest) | 2 mg, 28 tablets | Up to $25 if eligible | Up to $7.70 if eligible | $67.99† |
| Ryeqo (relugolix combination) | 28 tablets | Up to $25 if eligible | Up to $7.70 if eligible | $213.74† |
| Diphereline (triptorelin) | 3.75 mg injection | PBS price if eligible | PBS price if eligible | Not verified |
| Zoladex (goserelin) | 3.6 mg implant | PBS price if eligible | PBS price if eligible | Not verified |
† Retailer prices checked on 24 October 2026: Pharmax listed Visanne 2 mg (28 tablets) at $67.99, and Chemist2U listed Ryeqo (28 tablets) at $213.74. Diphereline and Zoladex private prices were not verified. Pharmacy prices, stock and applicable premiums can change.
Why can the private price be so different?
A published pharmacy example for 28 Ryeqo tablets is $213.74. Compared with the 2026 maximum standard PBS co-payment of $25, that is a difference of $188.74 for this particular pack and retailer example, if the prescription qualifies and no additional premium applies.
That is not a guaranteed saving or proof of PBS eligibility. The medicine, prescribed indication and relevant listing conditions all matter. Before paying a private price, ask your pharmacist whether your prescription can be dispensed under the PBS.
Visanne: dienogest
Dienogest 2 mg is PBS-listed for endometriosis under the applicable streamlined authority conditions. The Australian Government has reported that some people previously paid around $750 or more each year before subsidised access.
A retailer price example cited in October 2026 is $67.99 for 28 tablets. For an eligible PBS prescription, the 2026 standard co-payment is up to $25 for a general patient or $7.70 for a concession card holder, plus any applicable premium. Different brands, strengths or pack arrangements may affect the price.
Ryeqo: relugolix combination therapy
Ryeqo contains relugolix, estradiol and norethisterone acetate. It became PBS-listed for eligible endometriosis prescriptions in 2025, subject to the applicable prescribing criteria.
The Australian Government reported that some patients previously faced treatment costs of up to $2,700 a year. A pharmacy example cited in October 2026 is $213.74 for 28 tablets. Ask your prescriber or pharmacist whether the current PBS criteria apply to your prescription.
Diphereline: triptorelin
From 1 October 2026, the PBS listing for Diphereline 3.75 mg was expanded to include endometriosis among several women's-health indications. The Australian Government said treatment without subsidy could cost more than $1,370 per prescription.
For an eligible PBS prescription, the standard 2026 co-payment is up to $25 for general patients or $7.70 for concession card holders. The listing change does not mean this treatment is suitable for everyone.
Zoladex: goserelin
PBS access to the monthly Zoladex 3.6 mg implant was extended until 1 May 2027, after a previously planned November 2026 delisting. Under the announced arrangement, eligible PBS prescriptions written by 30 April 2027 can be dispensed until 1 May 2028.
Availability and individual eligibility can vary. Check the latest arrangements with your pharmacist or prescriber.
What if my medicine is prescribed privately?
A private prescription may cost more than an eligible PBS prescription. The amount can depend on the medicine, formulation, pack size and pharmacy. Ask the pharmacy to explain the price and check whether the prescribed item and indication meet PBS conditions.
Keep prescriptions ready for the next appointment
When medicines, repeats and expiry dates are recorded in different places, it can be difficult to know what needs attention next. Keeping those details together can help you prepare for a pharmacy visit or GP appointment.
MediRemind can organise the prescription details and reminders you enter. It does not determine which treatment is appropriate, confirm PBS eligibility, issue prescriptions or replace your pharmacy's dispensing record.
Frequently asked questions
How much does endometriosis treatment cost in Australia?
The 2026 maximum standard PBS co-payment is up to $25 for a general patient or $7.70 for a concession card holder per eligible prescription. Private prices vary by medicine, pack and pharmacy, and applicable premiums may affect the amount.
Which endometriosis medicines are on the PBS?
Dienogest (including Visanne), Ryeqo and, from 1 October 2026, Diphereline 3.75 mg have PBS access for specified endometriosis prescriptions. Zoladex 3.6 mg access has been extended until 1 May 2027. Coverage depends on the exact PBS item and applicable conditions; ask a pharmacist or prescriber to check your prescription.
Why might I pay more than $25 for an endometriosis medicine?
The prescription may be private, the specific item or indication may not meet PBS conditions, or a premium or other charge may apply. Ask your pharmacy to explain the price and whether PBS dispensing is available.
Are the private prices in this guide guaranteed?
No. The Visanne and Ryeqo amounts are examples from retailer listings cited in October 2026 research. Prices and stock can change, and the examples are not quotes for every pharmacy. Confirm the current amount with your pharmacy.
Where can I find an Endometriosis and Pelvic Pain Clinic?
The Australian Government provides a clinic finder for services across Australia. Check the map and contact a local clinic to confirm its services and current access.
Can MediRemind help me request a repeat prescription?
MediRemind can help you organise prescription details and send a request to your GP for an appointment when you need to discuss renewal. It does not issue prescriptions or guarantee an appointment.
Can my pharmacy dispense a repeat through MediRemind?
You can send a dispensing request to your chosen pharmacy through the supported app workflow. The pharmacist confirms whether a valid prescription and suitable supply arrangements are in place.
Sources and further information
- Australian Government: More choice, lower costs for one million women (7 September 2026)
- Pharmax: Visanne 2 mg, 28-tablet private-price example
- Chemist2U: Ryeqo, 28-tablet private-price example
- PBS: Dienogest 2 mg for endometriosis
- Australian Government: Expanded PBS listing for triptorelin (Diphereline)
- AstraZeneca: Zoladex monthly implant PBS extension (23 September 2026)
- Australian Government: Endometriosis and Pelvic Pain Clinics and clinic finder
- Services Australia: PBS Safety Net thresholds
Prices and PBS arrangements can change. MediRemind provides prescription and medication management tools and does not prescribe, supply or recommend medicines. Speak with your doctor or pharmacist about your individual treatment.